Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

NCT00971477 | Completed Phase 2

• 1 other identifier: 2009172431
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction. The investigators' hypotheses include the following:

1. 1.Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
2. 2.Compared to in-person visits, the online care model will result in similar improvements in quality of life.
3. 3.Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Conditions

Psoriasis

Keywords

Teledermatology; Telemedicine; Psoriasis

Outcome Measures

Primary Outcomes (1)

• Psoriasis Area Severity Index (PASI)

  Every 6-8 weeks

Study Arms (2)

Teledermatology

EXPERIMENTAL

Online Telemedicine Group

Other: Online Teledermatology Care

Usual Care

ACTIVE COMPARATOR

Conventional in-office care

Other: Conventional in Office Care

Interventions

Online Teledermatology Care OTHER

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

Also known as: Health care service modality

Teledermatology

Conventional in Office Care OTHER

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Also known as: Health care service modality

Usual Care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years of age or older at time of consent, may be men or women.
• Requiring treatment of psoriasis for medically-indicated reasons.
• Capable of giving informed consent.
• Able to have their skin imaged by themselves or by family members.

You may not qualify if:

• Non-English speaking individuals.
• Individuals lacking access to a digital camera and computer with internet connection.

Sponsors & Collaborators

• University of California, Davis: lead

Study Sites (1)

UC Davis Department of Dermatology

Sacramento, California, 95816, United States

Location

MeSH Terms

Conditions

Psoriasis

Interventions

Congresses as Topic

Condition Hierarchy (Ancestors)

Skin Diseases, Papulosquamous; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Organizations; Health Care Economics and Organizations

Study Officials

• April W Armstrong, MD

  UC Davis Department of Dermatology

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 1, 2009
• First Posted: September 3, 2009
• Study Start: August 1, 2009
• Primary Completion: June 1, 2010
• Study Completion: June 1, 2010
• Last Updated: December 13, 2010

Record last verified: 2010-12

Locations

US (1)